Drug intelligence / Profile preview

Golytely + bisacodyl

Development stage
Unknown
Lead developer
University of British Columbia
Modality
Small Molecules
Administration
Oral
01

Overview

Golytely + bisacodyl is a combination bowel preparation regimen being evaluated for inpatient colonoscopy. It consists of a reduced volume (2 liters) of polyethylene glycol 3350 with electrolytes (Golytely) combined with 15 mg of the stimulant laxative bisacodyl. Golytely acts as an osmotic laxative, inducing a watery stool by retaining water in the intestinal lumen through osmotic pressure. Bisacodyl is a stimulant laxative that acts directly on the colonic mucosa and the enteric nervous system to stimulate peristalsis. This combination aims to provide similar bowel cleansing efficacy to the standard 4-liter Golytely regimen while offering better patient tolerability and compliance due to the lower fluid volume required.

Brand names
Dulcolax
Other names
2L Golytely/bisacodylPEG-3350 with electrolytes plus bisacodylPEG3350 with electrolytes plus bisacodylPEG 3350 with electrolytes plus bisacodyl
02

Targets

AQP3 (Aquaporin-3 channel protein)

Beyond the preview

Go deeper on Golytely + bisacodyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golytely + bisacodyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call